211 related articles for article (PubMed ID: 31440926)
1. Squamous Cell Carcinoma with Regional Metastasis to Axilla or Groin Lymph Nodes: a Multicenter Outcome Analysis.
Pang G; Look Hong NJ; Paull G; Dobransky J; Kupper S; Hurton S; Kagedan DJ; Quan ML; Helyer L; Nessim C; Wright FC
Ann Surg Oncol; 2019 Dec; 26(13):4642-4650. PubMed ID: 31440926
[TBL] [Abstract][Full Text] [Related]
2. Cutaneous squamous cell carcinoma metastatic to the axilla and groin: Outcomes and prognostic factors.
Bucknell NW; Gyorki DE; Bressel M; Estall V; Webb A; Henderson M; Chua MS; Rischin D; Tiong A
Australas J Dermatol; 2022 Feb; 63(1):43-52. PubMed ID: 34751431
[TBL] [Abstract][Full Text] [Related]
3. Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck.
Moore BA; Weber RS; Prieto V; El-Naggar A; Holsinger FC; Zhou X; Lee JJ; Lippman S; Clayman GL
Laryngoscope; 2005 Sep; 115(9):1561-7. PubMed ID: 16148695
[TBL] [Abstract][Full Text] [Related]
4. Managing patients with cutaneous squamous cell carcinoma metastatic to the axilla or groin lymph nodes.
Goh A; Howle J; Hughes M; Veness MJ
Australas J Dermatol; 2010 May; 51(2):113-7. PubMed ID: 20546217
[TBL] [Abstract][Full Text] [Related]
5. Association Between Lymph Node Ratio and Recurrence and Survival Outcomes in Patients With Oral Cavity Cancer.
Ding D; Stokes W; Eguchi M; Hararah M; Sumner W; Amini A; Goddard J; Somerset H; Bradley C; McDermott J; Raben D; Karam SD
JAMA Otolaryngol Head Neck Surg; 2019 Jan; 145(1):53-61. PubMed ID: 30452499
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic lymph node dissection in melanoma: different prognosis for different macrometastasis sites?
Wevers KP; Bastiaannet E; Poos HP; van Ginkel RJ; Plukker JT; Hoekstra HJ
Ann Surg Oncol; 2012 Nov; 19(12):3913-8. PubMed ID: 22588472
[TBL] [Abstract][Full Text] [Related]
7. Association of Disease Recurrence With Survival Outcomes in Patients With Cutaneous Squamous Cell Carcinoma of the Head and Neck Treated With Multimodality Therapy.
Sun L; Chin RI; Gastman B; Thorstad W; Yom SS; Reddy CA; Nussenbaum B; Wang SJ; Knackstedt T; Vidimos AT; Koyfman SA; Manyam BV
JAMA Dermatol; 2019 Apr; 155(4):442-447. PubMed ID: 30810715
[TBL] [Abstract][Full Text] [Related]
8. Lymph-node-positive cutaneous nonmelanoma skin cancer: A poor-prognosis disease in need of treatment intensification.
Wang LS; Handorf EA; Ridge JA; Burtness BA; Lango MN; Mehra R; Liu JC; Galloway TJ
Ear Nose Throat J; 2017 Jul; 96(7):E12-E18. PubMed ID: 28719713
[TBL] [Abstract][Full Text] [Related]
9. Association of Adjuvant Radiation Therapy With Survival in Patients With Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck.
Harris BN; Pipkorn P; Nguyen KNB; Jackson RS; Rao S; Moore MG; Farwell DG; Bewley AF
JAMA Otolaryngol Head Neck Surg; 2019 Feb; 145(2):153-158. PubMed ID: 30570645
[TBL] [Abstract][Full Text] [Related]
10. Sentinel lymph node biopsy for high-risk cutaneous squamous cell carcinoma: Analysis of recurrence-free survival.
Samsanavičius D; Kaikaris V; Norvydas SJ; Liubauskas R; Valiukevičienė S; Makštienė J; Maslauskas K; Rimdeika R
Medicina (Kaunas); 2016; 52(5):276-282. PubMed ID: 27746117
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with regional recurrence after lymph node dissection for penile squamous cell carcinoma.
Reddy JP; Pettaway CA; Levy LB; Pagliaro LC; Tamboli P; Rao P; Jayaratna I; Hoffman KE
BJU Int; 2017 Apr; 119(4):591-597. PubMed ID: 27753187
[TBL] [Abstract][Full Text] [Related]
12. Deep lymph node metastases in the groin significantly affects prognosis, particularly in sentinel node-positive melanoma patients.
Niebling MG; Wevers KP; Suurmeijer AJ; van Ginkel RJ; Hoekstra HJ
Ann Surg Oncol; 2015 Jan; 22(1):279-86. PubMed ID: 25008028
[TBL] [Abstract][Full Text] [Related]
13. Analysis of selected risk factors for nodal metastases in head and neck cutaneous squamous cell carcinoma.
Szewczyk M; Pazdrowski J; Golusiński P; Dańczak-Pazdrowska A; Marszałek S; Golusiński W
Eur Arch Otorhinolaryngol; 2015 Oct; 272(10):3007-12. PubMed ID: 25217080
[TBL] [Abstract][Full Text] [Related]
14. Oncologic Outcomes According to Remnant Lymph Node Metastases in Pathologic T0 (ypT0) Esophageal Squamous Cell Carcinoma Following Prospective Neoadjuvant Therapy and Surgery.
Cho HJ; Kim YH; Kim HR; Kim DK; Park SI; Kim JH; Kim SB
Ann Surg Oncol; 2015; 22(6):1851-7. PubMed ID: 25344308
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous squamous cell carcinoma metastatic to parotid - analysis of prognostic factors and treatment outcome.
Goh RY; Bova R; Fogarty GB
World J Surg Oncol; 2012 Jun; 10():117. PubMed ID: 22731750
[TBL] [Abstract][Full Text] [Related]
16. Nodal basin recurrence following lymph node dissection for melanoma: implications for adjuvant radiotherapy.
Lee RJ; Gibbs JF; Proulx GM; Kollmorgen DR; Jia C; Kraybill WG
Int J Radiat Oncol Biol Phys; 2000 Jan; 46(2):467-74. PubMed ID: 10661355
[TBL] [Abstract][Full Text] [Related]
17. Suboptimal Outcomes in Cutaneous Squamous Cell Cancer of the Head and Neck with Nodal Metastases.
Varra V; Woody NM; Reddy C; Joshi NP; Geiger J; Adelstein DJ; Burkey BB; Scharpf J; Prendes B; Lamarre ED; Lorenz R; Gastman B; Manyam BV; Koyfman SA
Anticancer Res; 2018 Oct; 38(10):5825-5830. PubMed ID: 30275206
[TBL] [Abstract][Full Text] [Related]
18. The number of removed lymph nodes by inguinofemoral lymphadenectomy: impact on recurrence rates in patients with vulva carcinoma.
Diehl A; Volland R; Kirn V; Thangarajah F; Eichler C; Einzmann T; Wirtz M; Ratiu D; Morgenstern B; Fridrich C; Mallmann P; Puppe J
Arch Gynecol Obstet; 2016 Jul; 294(1):131-6. PubMed ID: 26498758
[TBL] [Abstract][Full Text] [Related]
19. Factors predictive of recurrence and death from cutaneous squamous cell carcinoma: a 10-year, single-institution cohort study.
Schmults CD; Karia PS; Carter JB; Han J; Qureshi AA
JAMA Dermatol; 2013 May; 149(5):541-7. PubMed ID: 23677079
[TBL] [Abstract][Full Text] [Related]
20. Extracapsular growth of lymph node metastases in squamous cell carcinoma of the vulva. The impact on recurrence and survival.
van der Velden J; van Lindert AC; Lammes FB; ten Kate FJ; Sie-Go DM; Oosting H; Heintz AP
Cancer; 1995 Jun; 75(12):2885-90. PubMed ID: 7773938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
